Medipost Co (XKRX:078160) COGS-to-Revenue : 0.44 (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is Medipost Co COGS-to-Revenue?

Medipost Co's Cost of Goods Sold for the three months ended in Dec. 2023 was ₩7,508 Mil. Its Revenue for the three months ended in Dec. 2023 was ₩17,043 Mil.

Medipost Co's COGS to Revenue for the three months ended in Dec. 2023 was 0.44.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Medipost Co's Gross Margin % for the three months ended in Dec. 2023 was 55.95%.

Medipost Co COGS-to-Revenue Historical Data

The historical data trend for Medipost Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medipost Co COGS-to-Revenue Chart

Medipost Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.37

0.36

0.42

0.40

0.41

Medipost Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial															0.30	0.40	0.39	0.42	0.44

Medipost Co COGS-to-Revenue Calculation

Medipost Co's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	28458.839	/	68642.987
	=	0.41

Medipost Co's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	7507.74	/	17042.788
	=	0.44

Medipost Co (XKRX:078160) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Medipost Co's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	7507.74 / 17042.788
	=	55.95 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Medipost Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Medipost Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Medipost Co (XKRX:078160) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medipost Co Ltd (XKRX:078160) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

21, Daewangpangyo-ro 644, Bundang-gu, Gyeonggi-do, Seongnam, KOR

Website

http://www.medi-post.co.kr

Medipost Co Ltd is a Korea-based stem cell biotechnology company. The company is engaged in developing products to meet unmet medical needs. The company operates its business through four distinct segments: Stem Cell Therapeutics, Cord Blood Bank, Cosmetics, and Health Supplements. The Cord Blood Bank Division is involved in collecting and storing stem cells from the newborn's umbilical cord. The Stem Cell Therapeutics division manufactures allogeneic stem cell drug products. The Health Supplements division offers vitamins and nutritional supplements. The Cosmetics division is involved in the sales and marketing of natural cosmetics.

Medipost Co (XKRX:078160) Headlines

No Headlines